Ophthalmology Times Europe Newsletter

To view this email as a web page, click here.

Sustained-release implant promising for long-term IOP reduction

E. Randy Craven, MD, discusses sustained-release implants for long-term IOP reduction, which he shared at the annual ASCRS 2019 meeting in San Diego.

Nerve growth factor promising for dry eye

Recombinant human nerve growth factor (rhNGF) has shown promise as a treatment for dry eye disease in a phase I clinical trial.

Children with behavioural problems run a risk from laser pointers

Children with behavioural problems may hurt themselves with laser pointers, and eye-care professionals should be alert to the risk, researchers say.

Considering BID ocular steroid post-cataract surgery

Rho kinase inhibitors getting to the heart of the matter

Managing unique challenges of pediatric congenital cataract

Primary posterior optic capture offers many advantages in cataract surgery

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.